Osteoporosis Home > Ipriflavone

What You Need to Know About Ipriflavone

Ipriflavone, a synthetic isoflavone, has shown some promise in its ability to preserve bone in postmenopausal women. The product has also been shown to have a protective effect on bone density in premenopausal women taking the treatment called GnRH (gonadotropin-releasing hormone), which is for endometriosis. One of the side effects of this treatment is bone loss.
However, a definitive three-year study of more than 400 postmenopausal women concluded that ipriflavone did not prevent bone loss.
In addition, the compound was linked to lymphocytopenia (a reduction in lymphocytes) in a significant number of study participants. Lymphocytes are a type of white blood cell that helps the body fight infection.
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Topics & Medications


Related Channels

eMedTV Links
Copyright © 2006-2020 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.